Finance

Lists
Q3 2026 earnings • released • EPS beat +11.46% • Revenue beat +1.38%
See results
DD:NYSE
DuPont de Nemours Inc
$146.52
+1.10%
(+1.59) 1D
$146.52
0.00% (0.00)
After hours
Closed: Nov 6, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DD...
Open
$144.98
High
$147.76
Low
$144.05
Mkt. cap
19.42B
Avg. vol.
1.01M
Volume
975.76K
Dividend
1.64%
Quarterly dividend
$0.60
Ex-dividend date
Nov 30, 2026
P/E ratio
66.24
52-wk high
$157.98
52-wk low
$111.15
EPS
$2.21
Beta
1.05
Shares outstanding
132.53M
No. of employees
15K
Open
$144.98
High
$147.76
Low
$144.05
Mkt. cap
19.42B
Avg. vol.
1.01M
Volume
975.76K
Dividend
1.64%
Quarterly dividend
$0.60
Ex-dividend date
Nov 30, 2026
P/E ratio
66.24
52-wk high
$157.98
52-wk low
$111.15
EPS
$2.21
Beta
1.05
Shares outstanding
132.53M
No. of employees
15K
News stories
From web sources and news partners
Profile
DuPont de Nemours, Inc., commonly shortened to DuPont, is a company headquartered and organized in Delaware that produces products for the healthcare, water, construction and industrial markets. It was formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company operates two divisions: Healthcare & Water Technologies, which produces medical packaging such as Tyvek packaging and Tychem protective suits as well as Amberlite ion exchange resins, Filmtec reverse osmosis and nanofiltration elements and Inge and Itegratec ultrafiltration modules; and Diversified Industrials, which produces products for repair‑and‑remodel construction such as Tyvek house wrap, Styrofoam insulation, Corian, Vespel shapes and parts, Molykote lubricants, Betaforce, and Betaseal. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder. Wikipedia
About DuPont de Nemours Inc
CEOLori Koch
Employees15K
FoundedAug 31, 2017
Headquarters-
SectorIndustrials
IndustryConglomerate
Websitedupont.com
Analyst ratings
Based on 12 analysts giving stock ratings to DD in the past 3 months
Buy
Buy
8
Hold
4
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for DD in the last 3 months.
Highest
Current $146.52
$186.00 (+26.95%)
Average
$168.50 (+15.00%)
Lowest
$145.00 (-1.04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Arun Viswanathan
RBC Capital
Buy
Maintained
$173.00
+18.1%
11/04/2026
Abigail Eberts
Wells Fargo
Buy
Reiterated
$170.00
+16%
11/05/2026
John McNulty
BMO Capital
Buy
Maintained
$186.00
+26.9%
11/03/2026
Joshua Spector
UBS
Buy
Maintained
$182.00
+24.2%
11/04/2026
Patrick Cunningham
Citi
Buy
Maintained
$176.00
+20.1%
11/04/2026
Vincent Andrews
Morgan Stanley
Hold
Maintained
$156.00
+6.5%
11/04/2026
Matthew DeYoe
Bank of America Securities
Hold
Reiterated
$168.00
+14.7%
11/04/2026
John Roberts CFA
Mizuho Securities
Buy
Maintained
$165.00
+12.6%
11/04/2026
Joe Ritchie
Goldman Sachs
Hold
Maintained
$169.00
+15.3%
11/04/2026
Aleksey Yefremov
Barclays
Buy
Maintained
$176.00
+20.1%
11/04/2026
Michael Leithead
Barclays
Buy
Initiated
$156.00
+6.5%
10/12/2026
Chigusa Katoku
J.P. Morgan
Hold
Downgraded
$145.00
-1%
10/09/2026
Alexandra Yates
Argus Research
Buy
Reiterated
$156.00
+6.5%
10/05/2026
Michael Sison
Wells Fargo
Buy
Reiterated
$165.00
+12.6%
05/26/2026
David Begleiter
Deutsche Bank
Buy
Maintained
$180.00
+22.9%
05/07/2026
Laurence Alexander
Jefferies
Buy
Maintained
$59.00
-59.7%
02/11/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
$2.09 / $1.88
+11.46%beat
Revenue / Est. (USD)
1.87B / 1.84B
+1.38%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-1.87B
1.68B
1.82B
1.87B
Cost of goods sold
-816.00M
1.08B
1.18B
1.20B
Cost of revenue
-816.00M
1.08B
1.18B
1.20B
Research and development expenses
-211.00M
47.00M
42.00M
42.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-111.00M
255.00M
270.00M
262.00M
Operating expense
-406.00M
370.00M
380.00M
372.00M
Total operating expenses
-1.22B
1.45B
1.56B
1.57B
Operating income
-649.00M
232.00M
259.00M
295.00M
Other non operating income
2.00M
10.00M
4.00M
1.00M
EBT including unusual items
-738.00M
181.00M
266.00M
279.00M
EBT excluding unusual items
-719.00M
221.00M
262.00M
294.00M
Income tax expense
-89.00M
31.00M
75.00M
108.00M
Effective tax rate
12.06%
17.13%
28.20%
38.71%
Other operating expenses
-
-
-
-
Net income
-126.00M
161.00M
143.00M
123.00M
Net profit margin
6.73%
9.58%
7.86%
6.58%
Earnings per share
1.38
1.65
1.88
2.09
Interest and investment income
30.00M
10.00M
27.00M
27.00M
Interest expense
-64.00M
-40.00M
-41.00M
-40.00M
Net interest expenses
-34.00M
-30.00M
-14.00M
-13.00M
Depreciation and amortization charges
-84.00M
-
-
-
EBITDA
-487.25M
387.00M
413.00M
450.00M
Gain or loss from assets sale
-3.00M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps